Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenetic Biosciences (XBIO) Return on Assets (2023 - 2025)

Xenetic Biosciences' Return on Assets history spans 6 years, with the latest figure at 0.42% for Q4 2025.

  • For Q4 2025, Return on Assets rose 14.0% year-over-year to 0.42%; the TTM value through Dec 2025 reached 0.42%, up 14.0%, while the annual FY2025 figure was 0.37%, 11.0% up from the prior year.
  • Return on Assets reached 0.42% in Q4 2025 per XBIO's latest filing, up from 0.64% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.4% in Q4 2023 to a low of 0.66% in Q1 2023.
  • Average Return on Assets over 3 years is 0.55%, with a median of 0.55% recorded in 2024.
  • The largest YoY upside for Return on Assets was 17bps in 2024 against a maximum downside of -16bps in 2024.
  • A 3-year view of Return on Assets shows it stood at 0.4% in 2023, then plummeted by -41bps to 0.56% in 2024, then grew by 25bps to 0.42% in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Return on Assets are 0.42% (Q4 2025), 0.64% (Q3 2025), and 0.59% (Q2 2025).